Incidence and characteristics of metabolic disorders and vascular complications in individuals with Werner syndrome in Japan

Journal of the American Geriatrics Society

Volumn 60, Issue 5, 2012, Pages 997-998

  Okabe, Emiko ^a   Takemoto, Minoru ^a   Onishi, Shunichiro ^a   Ishikawa, Takahiro ^a   Ishibashi, Ryouichi ^a   He, Peng ^a   Kobayashi, Kazuki ^a   Fujimoto, Masaki ^a   Kawamura, Harukiyo ^a   Yokote, Koutaro ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; PIOGLITAZONE; SULFONYLUREA;

ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; JAPAN; LETTER; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORBIDITY; VASCULAR DISEASE; WERNER SYNDROME;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; METABOLIC DISEASES; MIDDLE AGED; VASCULAR DISEASES; WERNER SYNDROME; YOUNG ADULT;

EID: 84862086573     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2012.03944.x     Document Type: Letter

References (3)

1. Epstein CJ, Martin GM, Schultz AL, et al. Werner's syndrome: A review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 1966; 45: 177-221.
2. Yokote K, Honjo S, Kobayashi K, et al. Metabolic improvement and abdominal fat redistribution in Werner syndrome by pioglitazone. J Am Geriatr Soc 2004; 52: 1582-1583.
3. Opresko PL,. Telomere ResQue and preservation roles for the Werner syndrome protein and other RecQ helicases. Mech Ageing Dev 2008; 129: 79-90.